This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hovey, R. M. Articles by Waldman, F. M. Search for Related Content PubMed PubMed Citation Articles by Hovey, R. M. Articles by Waldman, F. M.

Genetic Alterations in Primary Bladder Cancers and Their Metastases¹

Department of Urology, University of California San Francisco, San Francisco, California 94143-0738 [R. M. H., P. R. C.]; Cancer Genetics Program, University of California San Francisco Cancer Center, San Francisco, California 94143-0808 [L. C., M. B., S. D., D. M., F. M. W.]; and Department of Pathology, University of Basel, 4003 Basel, Switzerland [G. S.]

Bladder cancer progression is thought to be associated with sequential genetic events. To search for the specific genetic changes associated with the metastatic process, comparative genomic hybridization was performed on 22 primary tumors and 24 metastases (10 distant and 14 nodal metastases) from 17 patients with stage pT2–4 bladder cancer. There was a striking similarity between the genetic alterations present in the primary and metastatic tumor samples from the same patient. The mean number of genetic changes/tumor was 12.2 for primary tumors and 11.7 for metastases. There was a strong concordance in the specific aberrations present in each patient's primary and metastatic lesions (mean, 75%). Concordance was also high among multiple sites from an individual primary tumor (mean, 96%) and multiple metastases from the same patient (mean, 75%). There were no specific genetic changes overrepresented in the metastases compared with their primary tumors. Genetic alterations present in more than 40% of tumors included gains on 6p, 8q, 10q, and 17q and losses involving 8p, 10q, and Y. Two regions of high-level amplification were common: (a) 10q22.1–q23.1 (32.6%); and (b) 17q11–21.3 (23.9%; the locus of erbB-2). A summary statistic was developed to quantitate the degree of clonal relationships between biopsies from the same patient. These data support a model in which minimal clonal evolution occurs in the metastatic tumor cell population after the metastatic event. When comparing primary cancers from patients with and without metastases, however, several unique genetic changes were identified in those cancers with metastases, suggesting that these loci may harbor genes important to the metastatic process.

¹ Supported by NIH Grant CA47537.

² To whom requests for reprints should be addressed, at Cancer Genetics Program, University of California San Francisco Cancer Center, San Francisco, CA 94143-0808.

Received 4/ 1/98. Accepted 6/30/98.

This article has been cited by other articles:

				G. C Santos, M Zielenska, M Prasad, and J A Squire Chromosome 6p amplification and cancer progression J. Clin. Pathol., January 1, 2007; 60(1): 1 - 7. [Abstract] [Full Text] [PDF]

				M. A. Knowles Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis, March 1, 2006; 27(3): 361 - 373. [Abstract] [Full Text] [PDF]

				E. Blaveri, J. L. Brewer, R. Roydasgupta, J. Fridlyand, S. DeVries, T. Koppie, S. Pejavar, K. Mehta, P. Carroll, J. P. Simko, et al. Bladder Cancer Stage and Outcome by Array-Based Comparative Genomic Hybridization Clin. Cancer Res., October 1, 2005; 11(19): 7012 - 7022. [Abstract] [Full Text] [PDF]

				L. E. Moore, A. H. Smith, C. Eng, D. Kalman, S. DeVries, V. Bhargava, K. Chew, D. Moore II, C. Ferreccio, O. A. Rey, et al. Arsenic-Related Chromosomal Alterations in Bladder Cancer J Natl Cancer Inst, November 20, 2002; 94(22): 1688 - 1696. [Abstract] [Full Text] [PDF]

				M A Knowles What we could do now: molecular pathology of bladder cancer Mol. Pathol., August 1, 2001; 54(4): 215 - 221. [Abstract] [Full Text] [PDF]

				I. D.C. Markl, J. Cheng, G. Liang, D. Shibata, P. W. Laird, and P. A. Jones Global and Gene-specific Epigenetic Patterns in Human Bladder Cancer Genomes Are Relatively Stable in Vivo and in Vitro over Time Cancer Res., August 1, 2001; 61(15): 5875 - 5884. [Abstract] [Full Text] [PDF]

				J.-i. Ohta, Y. Miyoshi, H. Uemura, K. Fujinami, K. Mikata, M. Hosaka, Y. Tokita, and Y. Kubota Fluorescence in Situ Hybridization Evaluation of c-erbB-2 Gene Amplification and Chromosomal Anomalies in Bladder Cancer Clin. Cancer Res., August 1, 2001; 7(8): 2463 - 2467. [Abstract] [Full Text] [PDF]

				Y. H. Kim, N.-G. Kim, J. G. Lim, C. Park, and H. Kim Chromosomal Alterations in Paired Gastric Adenomas and Carcinomas Am. J. Pathol., February 1, 2001; 158(2): 655 - 662. [Abstract] [Full Text] [PDF]

				M. Muscheck, H. Abol-Enein, K. Chew, D. Moore II, V. Bhargava, M.A. Ghoneim, P.R. Carroll, and F.M. Waldman Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization Carcinogenesis, September 1, 2000; 21(9): 1721 - 1726. [Abstract] [Full Text] [PDF]

				J. Richter, U. Wagner, J. Kononen, A. Fijan, J. Bruderer, U. Schmid, D. Ackermann, R. Maurer, G. Alund, H. Knonagel, et al. High-Throughput Tissue Microarray Analysis of Cyclin E Gene Amplification and Overexpression in Urinary Bladder Cancer Am. J. Pathol., September 1, 2000; 157(3): 787 - 794. [Abstract] [Full Text] [PDF]

				P. J. Grippo and E. P. Sandgren Highly Invasive Transitional Cell Carcinoma of the Bladder in a Simian Virus 40 T-Antigen Transgenic Mouse Model Am. J. Pathol., September 1, 2000; 157(3): 805 - 813. [Abstract] [Full Text] [PDF]

				W.’e. El-Rifai, D. Kamel, M. L. Larramendy, S. Shoman, Y. Gad, S. Baithun, M. El-Awady, S. Eissa, H. Khaled, S. Soloneski, et al. DNA Copy Number Changes in Schistosoma-Associated and Non-Schistosoma-Associated Bladder Cancer Am. J. Pathol., March 1, 2000; 156(3): 871 - 878. [Abstract] [Full Text] [PDF]

				F. M. Waldman, S. DeVries, K. L. Chew, D. H. Moore II, K. Kerlikowske, and B.-M. Ljung Chromosomal Alterations in Ductal Carcinomas In Situ and Their In Situ Recurrences J Natl Cancer Inst, February 16, 2000; 92(4): 313 - 320. [Abstract] [Full Text] [PDF]

				N. Champagne, N. R. Bertos, N. Pelletier, A. H. Wang, M. Vezmar, Y. Yang, H. H. Heng, and X.-J. Yang Identification of a Human Histone Acetyltransferase Related to Monocytic Leukemia Zinc Finger Protein J. Biol. Chem., October 1, 1999; 274(40): 28528 - 28536. [Abstract] [Full Text] [PDF]

				D. F. Jarrard, S. Sarkar, Y. Shi, T. R. Yeager, G. Magrane, H. Kinoshita, N. Nassif, L. Meisner, M. A. Newton, F. M. Waldman, et al. p16/pRb Pathway Alterations Are Required for Bypassing Senescence in Human Prostate Epithelial Cells Cancer Res., June 1, 1999; 59(12): 2957 - 2964. [Abstract] [Full Text] [PDF]

				R. F. Willenbucher, D. E. Aust, C. G. Chang, S. J. Zelman, L. D. Ferrell, D. H. Moore II, and F. M. Waldman Genomic Instability Is an Early Event during the Progression Pathway of Ulcerative-Colitis-Related Neoplasia Am. J. Pathol., June 1, 1999; 154(6): 1825 - 1830. [Abstract] [Full Text] [PDF]